New Issue: Orbital Catastrophe Ahead? Read Now

‘PCOS is inaccurate’—why scientists renamed polycystic ovary syndrome

A multiyear effort to rename polycystic ovary syndrome finally revealed the condition’s new name: polyendocrine metabolic ovarian syndrome

A gynecological ultrasound of ovarian dystrophy.

A gynecological ultrasound.

Photo by BSIP/UIG via Getty Images

Join Our Community of Science Lovers!

Polycystic ovary syndrome (PCOS) is no more. The condition, of course, still exists. But on Tuesday a global science consortium announced the term will be thrown out. In a policy paper, the panel explained that the name was “inaccurate” because it didn’t fully capture the condition’s metabolic and endocrine features—including the fact that it likely affects men, too.

The condition will now be called polyendocrine metabolic ovarian syndrome (PMOS)—the group hopes the new diagnosis will be more accurate, reduce stigma and bolster research. The decision affects the estimated more than 170 million people who have the syndrome. Long thought to be a gynecological disease that only affected people with ovaries, evidence suggests it is much more than that. Signs of the condition can include obesity and hypertension, depression, eating disorders, acne and infertility, among others. These “multisystem health impacts,” the paper’s authors write, are why PCOS needed to be reclassified as PMOS.

Many people go undiagnosed or misdiagnosed, while many more feel dissatisfied with their medical care and severe stigma, the authors write. Still, the effort to revise the term for the condition had stopped and started many times over the past two decades. Now researchers hope that the name change will spark new studies into syndrome, such as its genetic components—and perhaps potential treatments. Right now there is no U.S. Food and Drug Administration–approved therapeutic for the condition.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


First, the consortium needs to push through the new name change. In the policy paper, which was published in the Lancet, the authors lay out a plan for the World Health Organization and the International Classification of Diseases to adopt the new name over the next three years, meaning it could become the international standard in 2028.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe